Menu

Extreme Biotech: Understanding Extremophile Biology to Impact Human Health

Jaclyn Winter and Shiladitya DasSarma will discuss how they harness the unique biology of extremophiles for the discovery and development of new therapeutics.

The Scientist Creative Services Team
Aug 6, 2020

FREE Webinar

Tuesday, September 22, 2020
2:30 - 4:00 PM, Eastern Standard Time

Register Now

Extremophiles are best known to scientists for their contributions to PCR, but researchers are now harnessing the power of their unique biology to create new therapeutics from vaccine delivery to anti-cancer drugs. In this webinar from The Scientist, extremophile researchers Shiladitya DasSarma and Jaclyn Winter will discuss how they harness the unique biology of extremophiles for the discovery and development of new therapeutics and vaccines.

Topics to be covered

  • Harnessing the chemical potential of unprecedented microbes from the Great Salt Lake
  • Archaeal nanoparticles for therapeutics and vaccines

Register Now

Meet the Speakers:

Jaclyn Winter, PhD
Assistant Professor
Department of Medicinal Chemistry
University of Utah

Shiladitya DasSarma, PhD
Professor, Department of Microbiology and Immunology
University of Maryland School of Medicine
Professor, Institute of Marine and Environmental Technology
University System of Maryland

September 2020

Human Paths

Archaeology and genetics are starting to resolve humanity’s origin and spread

Marketplace

Sponsored Product Updates

Next-Generation Sequencing (NGS) Sample Preparation
Download this white paper to learn the best practices for optimizing sample homogenization in NGS nucleic acid extraction!
Bio-Rad Introduces StarBright Violet 515 Dyefor Flow Cytometry
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of StarBright Violet 515 (SBV515) Dye, the first of a new range of unique fluorescent nanoparticles, for use in flow cytometry.
Weighing the Benefits of a Clean Balance
Download this reference paper to learn the eight steps to a clean balance!
Predicting and Overcoming Resistance Using IsoPlexis' Single-Cell Intracellular Proteomic and Metabolomic Analysis Tools
Cancer cells develop resistance to targeted therapies, and their inherent functional heterogeneity makes it difficult for researchers to understand and characterize these resistance mechanisms. IsoPlexis' single-cell proteomics is helping researchers overcome resistance to targeted inhibitors, leading to better strategies and combination therapies.